Previous work has shown that certain autoantibodies are associated with different AD stages like MCI and AD, such as anti-ATCAY-IgG or anti-PAIP2-IgG, known to be associated with a higher risk of MCI and AD (Shim et al., 2022). The gene discussed is PAIP2; the disease is Alzheimer disease.